The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial
JMIR Mental Health · 2025-12-04 · 12 · e84323
DOI: 10.2196/84323 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Mental Health, published online on 2025-12-04. Written by Aric A Prather and 8 co-authors. Institution: University of California, San Francisco, San Francisco, CA, United States. Major MEDLINE topics: Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy. Cited 7 times so far (Crossref); 81 references. The full text is freely available in PubMed Central.
Topics: Schlaf
Abstract (original language)
Background
Cognitive behavioral therapy (CBT) is recommended as the first-line treatment for insomnia; however, few patients have access to it. A new class of Food and Drug Administration (FDA)–regulated digital CBT treatments has the potential to address this unmet need. These treatments are ordered or prescribed by health care providers and are fully automated, delivering CBT directly to patients without human coaches. This trial builds upon promising earlier digital cognitive behavioral therapy for insomnia (CBT-I) research by using a decentralized design to recruit a sample with greater representation of the US general population, including individuals from lower socioeconomic status groups who often face greater barriers to care.
Objective
This decentralized trial evaluated the effectiveness of a fully automated digital CBT-I program (SleepioRx) for treating insomnia disorder compared with online sleep hygiene education (SHE) in a sample of participants recruited from across the United States.
Methods
A decentralized, parallel-group randomized controlled trial was conducted between November 2022 and August 2023. Participants were recruited nationally from across the United States, and a total of 336 adults aged 22 and older, diagnosed with the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) insomnia disorder via structured clinical interview, were allocated 1:1 to either digital CBT-I (SleepioRx) or online SHE. The primary end points were insomnia severity, assessed using the Insomnia Severity Index (ISI), and sleep diary measures of sleep onset latency (SOL) and wake after sleep onset (WASO) at 10 weeks, with follow-up assessments at 16 and 24 weeks postrandomization.
Results
Compared with SHE, SleepioRx showed statistically and clinically significant improvements on the ISI at posttreatment (10 weeks; Cohen d=0.60, P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- University of California, San Francisco, San Francisco, CA, United States.
- King's College London, London, United Kingdom.
- Big Health, Inc, San Francisco, CA, United States.
- University of California, Berkeley, Berkeley, CA, United States.
- University of Oxford, Oxford, United Kingdom.
ORCID profiles: Aric A Prather, Andrew D Krystal, Richard Emsley, Jenna Carl, Tali Ball, Kathryn Tarnai, Adrian Aguilera, Colin A Espie, Alasdair L Henry
Cite
APA
Prather, A. A., Krystal, A. D., Emsley, R., Carl, J., Ball, T., Tarnai, K., Aguilera, A., Espie, C. A., & Henry, A. L. (2025). The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial. JMIR Mental Health, 12, e84323. https://doi.org/10.2196/84323
Vancouver
Prather AA, Krystal AD, Emsley R, Carl J, Ball T, Tarnai K, et al. The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial. JMIR Mental Health. 2025;12:e84323. doi:10.2196/84323
BibTeX
@article{Prather2025,
author = {Prather, Aric A and Krystal, Andrew D and Emsley, Richard and Carl, Jenna and Ball, Tali and Tarnai, Kathryn and Aguilera, Adrian and Espie, Colin A and Henry, Alasdair L},
title = {The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial},
journal = {JMIR Mental Health},
year = {2025},
volume = {12},
pages = {e84323},
doi = {10.2196/84323}
}
EUVIMED